focus -WSS

focus

author：hotspot 2025-10-02 21:07:24 - browse：1919

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Humana, CVS hope to turn members into patients at clinics

focus

hotspot

WSS

What the cancer research community can learn from the Covid response

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

My superpower is killing ticks

2 US Navy sailors arrested for allegedly spying for China

OTC birth control: A brief history of over the counter pill design

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

entertainment

focus

focus

How one medical school became remarkably diverse

My superpower is killing ticks

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ER docs worry over extreme heat as a 'mass casualty event'

Alkermes shareholders re

Verily hires former Apple Health leader as chief scientific officer

Jerome Adams on the need for new antivirals for Covid

A cyberattack has disrupted hospitals and health care in several states

Alkermes shareholders re

Humana, CVS hope to turn members into patients at clinics

focus

The drug industry sees a key ally in the Senate prevail

Influencer to be charged after chaos erupts in New York City's Union Square

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Humana, CVS hope to turn members into patients at clinics

Humana, CVS hope to turn members into patients at clinics

hotspot

knowledge

leisure time

leisure time